BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33355861)

  • 1. Autoimmune cytopenia in chronic lymphocytic leukemia: diagnosis and treatment.
    Yevstakhevych YL; Vyhovska YI; Yevstakhevych IY; Vyhovska OY; Pelenyo NV; Semerak MM; Novak VL; Loginsky VE
    Exp Oncol; 2020 Dec; 42(4):318-323. PubMed ID: 33355861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations.
    De Back TR; Kater AP; Tonino SH
    Expert Rev Hematol; 2018 Aug; 11(8):613-624. PubMed ID: 29923432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Michallet AS; Rossignol J; Cazin B; Ysebaert L
    Leuk Lymphoma; 2011 Jul; 52(7):1401-3. PubMed ID: 21699387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
    Rogers KA; Woyach JA
    Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 cases.
    Shvidel L; Tadmor T; Braester A; Bairey O; Rahimi-Levene N; Herishanu Y; Klepfish A; Shtalrid M; Berrebi A; Polliack A;
    Ann Hematol; 2013 May; 92(5):661-7. PubMed ID: 23274356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?
    Visco C; Cortelezzi A; Moretta F; Falisi E; Maura F; Finotto S; Barcellini W; Ambrosetti A; Neri A; Ruggeri M; Rodeghiero F
    Leuk Lymphoma; 2014 Jun; 55(6):1261-5. PubMed ID: 24047107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Kyasa MJ; Parrish RS; Schichman SA; Zent CS
    Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.
    Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL
    Leuk Lymphoma; 2009 Aug; 50(8):1261-8. PubMed ID: 19811329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.
    Mauro FR; Foa R; Cerretti R; Giannarelli D; Coluzzi S; Mandelli F; Girelli G
    Blood; 2000 May; 95(9):2786-92. PubMed ID: 10779422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
    Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
    Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Hodgson K; Ferrer G; Pereira A; Moreno C; Montserrat E
    Br J Haematol; 2011 Jul; 154(1):14-22. PubMed ID: 21534942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
    Tsang M; Parikh SA
    Curr Hematol Malig Rep; 2017 Feb; 12(1):29-38. PubMed ID: 28197963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic lymphocytic leukaemia. French Co-operative Group on CLL.
    Binet JL
    Baillieres Clin Haematol; 1993 Dec; 6(4):867-78. PubMed ID: 8038494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
    Leporrier M; Chevret S; Cazin B; Boudjerra N; Feugier P; Desablens B; Rapp MJ; Jaubert J; Autrand C; Divine M; Dreyfus B; Maloum K; Travade P; Dighiero G; Binet JL; Chastang C;
    Blood; 2001 Oct; 98(8):2319-25. PubMed ID: 11588025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence and prognostic significance of autoimmune cytopenias in a cohort of Egyptian patients with chronic lymphocytic leukemia.
    Atef B; Azmy E; Aladle D; Mabed M
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):97-104. PubMed ID: 30802421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of autoimmune cytopenia with ibrutinib in a chronic lymphocytic leukemia patient complicated by monoclonal immunoglobulin deposition disease].
    Nakamura M; Yoshioka S; Yamashita D; Hara S; Ishikawa T
    Rinsho Ketsueki; 2019; 60(10):1449-1454. PubMed ID: 31695006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.